Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Terazosin 2mg tablets and Terazosin 1mg tablets |
| BNF code | 0205040V0AAAAAA |
| Virtual Therapeutic Moiety | Terazosin |
| Date identifier became valid | 19 Oct 2018 |
| Previous product identifier | 318778006 |
| Basis of preferred name | Other |
| Combination product | Combination Product |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Non-availability | Actual Products not Available |
| Non-availability status date | 4 Nov 2024 |
| Dose form | Not applicable |
| Dose Form | |
|---|---|
| Formulation | Not applicable |
| Drug Route | |
| Route | Route of administration not applicable |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Virtual Medicinal Product Packs | |
| Terazosin 2mg tablets and Terazosin 1mg tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_12.2.0_20241216000001, imported on 17th December 2024 at 04:01:15.